Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Non Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05596097
What this trial is testing

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
LanZhou University 15
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Testing effectiveness (Phase 2)Ended earlyNCT06088654
What this trial is testing

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Innate Pharma 23
Early research (Phase 1)UnknownNCT05349266
What this trial is testing

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
Zhejiang University 16
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Not applicableUnknownNCT01231269
What this trial is testing

Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma

Who this might be right for
LymphomaHodgkin LymphomaNon-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma)
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05192486
What this trial is testing

GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00634179
What this trial is testing

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Who this might be right for
Lymphoma, B-CellFollicular Lymphoma
Emory University 37
Not applicableStudy completedNCT03985696
What this trial is testing

Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas

Who this might be right for
Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)
University Hospital, Limoges 90
Not applicableUnknownNCT00931229
What this trial is testing

Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
National Health Research Institutes, Taiwan 202
Testing effectiveness (Phase 2)Looking for participantsNCT07508605
What this trial is testing

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital 20
Not applicableStudy completedNCT07103486
What this trial is testing

Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 264
Testing effectiveness (Phase 2)Looking for participantsNCT07371923
What this trial is testing

Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02207062
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Transformed B-Cell Non-Hodgkin LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma
University of Washington 20
Not applicableAvailableNCT03123029
What this trial is testing

Expanded Access to Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Multiple MyelomaAcute Myeloid Leukemia (AML)+4 more
AbbVie
Not applicableStudy completedNCT04859920
What this trial is testing

Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region

Who this might be right for
Diffuse Large Cell Diffuse LymphomaFollicular Lymphoma
Centre Hospitalier Universitaire Dijon 157
Testing effectiveness (Phase 2)Study completedNCT00445341
What this trial is testing

Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 28
Not applicableStudy completedNCT06031194
What this trial is testing

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center 20
Early research (Phase 1)Study completedNCT00003166
What this trial is testing

Bryostatin and Vincristine in B-Cell Malignancies

Who this might be right for
Recurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+7 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)UnknownNCT00499018
What this trial is testing

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaIPI≥2
Fondazione Italiana Linfomi - ETS 399
Next Page